Both ticagrelor and prasugrel show evidence of a delay in the onset of antiplatelet action in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback